Jeena Sikho Lifecare Limited – Investor Presentation Summary

Key Operational Highlights

  • Operational beds: 2,424 with 460 more in pipeline
  • IPD volumes: 22,480 in H1FY27 (23% YoY growth)
  • OPD volumes: 3.1 lakh in H1FY27 (17% YoY growth)
  • Day care volumes: 27% YoY growth
  • Virtual OPD consultations: 1.36 lakh (39% YoY growth)
  • Network spans 62 hospitals and 60 clinics/day care centres across 23 states
  • 52 NABH-accredited units with 12 more in process
  • Covered 2,424 cities & towns

Key drivers of operational performance: Volume-led growth across both verticals, expanded network footprint, and increased patient conversions through health camps.

Segment-wise Performance

  • Ayurveda Healthcare Products: ₹262 crore (57% of H1FY27 revenue) with 87% gross margin
  • Healthcare Services: ₹197 crore (43% of H1FY27 revenue) with 90% gross margin

Explanation of significant changes in segment performance: Both verticals showed balanced growth with cross-selling between centres and product channels driving integrated model performance.

Financial Highlights

Revenue: ₹459.53 crore (H1FY27)

Gross Profit: ₹405.93 crore

Gross Profit Margin: 88%

EBITDA: ₹164.14 crore

EBITDA Margin: 36%

PAT: ₹102.03 crore

PAT Margin: 22%

EPS: ₹8.21 (basic)

YoY comparison: Revenue up 26% YoY from ₹364.13 crore in H1FY26, Gross Profit up 26% YoY, EBITDA down 4% YoY, PAT down 7% YoY

Q2FY27 specific: Revenue ₹235.13 crore (24% YoY growth), EBITDA ₹72.02 crore (31% margin), PAT ₹36.34 crore (15% margin), EPS ₹2.92

Drivers of financial performance: Volume-led revenue growth offset by increased operating expenses including advertisement/promotion (₹13.4 crore increase), employee benefits (₹4.1 crore increase), and ECL provision (₹2.5 crore increase).

Key Risks: Raw material price fluctuations, regulatory changes in AYUSH sector, collection experience from government customers.

Geographical Revenue Split

Domestic vs Export/Regional Revenue: Primarily domestic operations with pan-India presence across 23 states

Regional Breakdown: Operations span Assam, Bihar, Chandigarh, Chhattisgarh, Delhi, Goa, Gujarat, Haryana, Himachal Pradesh, Jammu and Kashmir, Jharkhand, Karnataka, Maharashtra, Madhya Pradesh, Odisha, Punjab, Rajasthan, Tamil Nadu, Telangana, Tripura, Uttar Pradesh, Uttarakhand, West Bengal

Balance Sheet Snapshot

Total Equity: ₹467.40 crore (FY26)

Non-current Liabilities: ₹102.31 crore (FY26)

Current Liabilities: ₹103.41 crore (FY26)

Property, Plant and Equipment: ₹117.01 crore (FY26)

Trade Receivables: ₹69.93 crore (FY26)

Cash and Cash Equivalents: ₹15.16 crore (FY26)

Financial Health Insights: Debt-free balance sheet, growth funded from internal accruals, strong cash flow generation from operations.

Capex & Cash Flow Health

Capital Expenditure: Ongoing expansion towards 5,000 beds target

Cash from Operating Activities: ₹261.99 crore (FY26)

Cash from Investing Activities: ₹(211.09) crore (FY26)

Cash from Financing Activities: ₹(58.73) crore (FY26)

Investment Rationale: Focus on capacity expansion, network growth, and entry into premium wellness segment.

Strategic & R&D Initiatives

Investments in Innovation: Clinical research on preventive Ayurveda, evidence-based studies on healthy individuals, planned patient study, 440+ SKU product portfolio expansion

Expected impact on growth: New product launches including Dr. DS range, protein & joint-care products, pharmacy & retail roll-out, own e-commerce platform

Strategic Rationale: Expanding into high-growth markets, premium wellness through Manali resort (108 rooms, 22 villas, helipad planned), and deepening clinical evidence base.

Industry Trends & Business Environment

Macro/Industry Trends: Growing global recognition of traditional medicine, WHO support through Global Centre for Traditional Medicine in Jamnagar, AYUSH-led policy measures, Ayush Visa category for wellness tourism, IRDA guidelines enabling health insurance coverage for Ayurveda

Impact on Company: Increasing institutional affordability, expanding market opportunity, government empanelments (CGHS, CAPF, ECHS, Uttar Pradesh, Bihar, Haryana, Punjab), and growing acceptance of Ayurveda treatments.

Management Commentary & Growth Outlook

Strategic Outlook: "Scale towards 5,000 beds over the next two to five years, improve utilisation of recently added capacity, broaden the product range and direct channels, and enter premium wellness through our first resort in Manali"

FY Guidance: Focus on capacity utilization improvement, product range expansion, and market share growth in underserved healthcare markets

Risks and Opportunities: Large underserved healthcare market with most Indian states below WHO recommendation of 3.0 beds per 1,000 population, rising private insurance coverage (58% of total lives covered in FY25 vs 35% in FY18)

ESG Updates

Not Specified

Digital Transformation

Not Specified